<--- Back to Details
First PageDocument Content
Chemistry / Organofluorides / Medullary thyroid cancer / Angiogenesis inhibitors / Vandetanib / Response Evaluation Criteria in Solid Tumors / End point of clinical trials / Thyroid neoplasm / Multiple endocrine neoplasia / Medicine / Oncology / Thyroid cancer
Chemistry
Organofluorides
Medullary thyroid cancer
Angiogenesis inhibitors
Vandetanib
Response Evaluation Criteria in Solid Tumors
End point of clinical trials
Thyroid neoplasm
Multiple endocrine neoplasia
Medicine
Oncology
Thyroid cancer

Signatory Authority Decisional Memorandum to the File

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 277,79 KB

Share Document on Facebook

Similar Documents

CMTF005 - Food is Medicine - Checklist_Debranded

DocID: 1xVMk - View Document

Cardiac electrophysiology / Medical devices / Neuroprosthetics / Medicine / Technology / Computing / Cybernetics / Implantable cardioverter-defibrillator / International Statistical Classification of Diseases and Related Health Problems / Universal Software Radio Peripheral / Artificial cardiac pacemaker / Radio-frequency identification

Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin†

DocID: 1xVge - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_with bleed

DocID: 1xUza - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_edited

DocID: 1xTtU - View Document

PDF Document

DocID: 1xSqy - View Document